| Filed | As-Of/On | Form | Fullname | Fund Class | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypotheticals Return |
Hypotheticals Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-11-18 | 2009-09-30 | 13F-HR | Jane Street Holding Llc | Institution | | Sold All | -45,085 | -100 % | | | | -11.90 % | $58,160 | | | | | | News Article | History of Jane Street Holding Llc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-18 | 2009-09-30 | 13F-HR | Sheets Smith And Associates Inc | Institution | 14,100 | New Holding | 14,100 | 100 % | $152,844 | $134,655 | $-18,189 | -11.90 % | $-18,189 | | | | | | News Article | History of Sheets Smith And Associates Inc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Amvescap Plc | Institution | 15,796 | No Change | 0 | 0 % | $176,441 | $150,852 | $-25,590 | -14.50 % | $0 | | | | | | News Article | History of Amvescap Plc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Credit Suisse First Boston | Institution | 10,635 | Sold Some | -31,030 | -74.47 % | $118,793 | $101,564 | $-17,229 | -14.50 % | $50,269 | | | | | | News Article | History of Credit Suisse First Boston Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR | Wells Fargo And Co | Institution | 126,929 | Added More | 107,329 | 547.59 % | $1,417,797 | $1,212,172 | $-205,625 | -14.50 % | $-173,873 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | American International Group Inc | Institution | 28,649 | Added More | 10,300 | 56.13 % | $352,956 | $273,598 | $-79,358 | -22.48 % | $-28,531 | | | | | | News Article | History of American International Group Inc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Bam Management Llc | No Data | 23,175 | Sold Some | -282,350 | -92.41 % | $285,516 | $221,321 | $-64,195 | -22.48 % | $782,110 | | | | | | News Article | History of Bam Management Llc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Bam Offshore Management Llc | No Data | 12,740 | New Holding | 12,740 | 100 % | $156,957 | $121,667 | $-35,290 | -22.48 % | $-35,290 | | | | | | News Article | History of Bam Offshore Management Llc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Black River Asset Management Llc | Institution | 15,000 | New Holding | 15,000 | 100 % | $184,800 | $143,250 | $-41,550 | -22.48 % | $-41,550 | | | | | | News Article | History of Black River Asset Management Llc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Bogle Investment Management L P | Institution | 226,301 | New Holding | 226,301 | 100 % | $2,788,028 | $2,161,175 | $-626,854 | -22.48 % | $-626,854 | | | | | | News Article | History of Bogle Investment Management L P Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Citadel L P | Institution | 46,955 | Added More | 29,761 | 173.08 % | $578,486 | $448,420 | $-130,065 | -22.48 % | $-82,438 | | | | | | News Article | History of Citadel L P Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fidelity International Ltd | Institution | 496,625 | Sold Some | -251,217 | -33.59 % | $6,118,420 | $4,742,769 | $-1,375,651 | -22.48 % | $695,871 | | | | | | News Article | History of Fidelity International Ltd Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fmr Corp | Institution | 1,549,500 | New Holding | 1,549,500 | 100 % | $19,089,840 | $14,797,725 | $-4,292,115 | -22.48 % | $-4,292,115 | | | | | | News Article | History of Fmr Corp Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ing Groep Nv | Institution | 10,490 | New Holding | 10,490 | 100 % | $129,237 | $100,180 | $-29,057 | -22.48 % | $-29,057 | | | | | | News Article | History of Ing Groep Nv Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Millennium Management Llc | Institution | 114,150 | New Holding | 114,150 | 100 % | $1,406,328 | $1,090,133 | $-316,196 | -22.48 % | $-316,196 | | | | | | News Article | History of Millennium Management Llc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Morgan Stanley | Institution | 264,699 | New Holding | 264,699 | 100 % | $3,261,092 | $2,527,875 | $-733,216 | -22.48 % | $-733,216 | | | | | | News Article | History of Morgan Stanley Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Corp | Institution | 303,032 | Added More | 143,331 | 89.74 % | $3,733,354 | $2,893,956 | $-839,399 | -22.48 % | $-397,027 | | | | | | News Article | History of Northern Trust Corp Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR/A | Oppenheimer Funds Inc | Institution | | Sold All | -3,200 | -100 % | | | | -22.48 % | $8,864 | | | | | | News Article | History of Oppenheimer Funds Inc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Orbimed Advisors Llc | Institution | 85,300 | Sold Some | -564,700 | -86.87 % | $1,050,896 | $814,615 | $-236,281 | -22.48 % | $1,564,219 | | | | | | News Article | History of Orbimed Advisors Llc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Perceptive Advisors Llc | Institution | 150,000 | Added More | 100,000 | 200.00 % | $1,848,000 | $1,432,500 | $-415,500 | -22.48 % | $-277,000 | | | | | | News Article | History of Perceptive Advisors Llc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Rbc Dominion Securities Inc | Institution | 23 | New Holding | 23 | 100 % | $283 | $220 | $-64 | -22.48 % | $-64 | | | | | | News Article | History of Rbc Dominion Securities Inc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Robotti Robert | Institution | 12,500 | No Change | 0 | 0 % | $154,000 | $119,375 | $-34,625 | -22.48 % | $0 | | | | | | News Article | History of Robotti Robert Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Shaw D E And Co Inc | Institution | 230,893 | Sold Some | -36,485 | -13.64 % | $2,844,602 | $2,205,028 | $-639,574 | -22.48 % | $101,063 | | | | | | News Article | History of Shaw D E And Co Inc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Tpg Capital Lp | No Data | 1,383,969 | No Change | 0 | 0 % | $17,050,498 | $13,216,904 | $-3,833,594 | -22.48 % | $0 | | | | | | News Article | History of Tpg Capital Lp Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Us Bancorp De | Institution | 1,582 | Added More | 40 | 2.59 % | $19,490 | $15,108 | $-4,382 | -22.48 % | $-111 | | | | | | News Article | History of Us Bancorp De Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Vicis Capital Llc | Institution | 116,380 | New Holding | 116,380 | 100 % | $1,433,802 | $1,111,429 | $-322,373 | -22.48 % | $-322,373 | | | | | | News Article | History of Vicis Capital Llc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Ameriprise Financial Inc | Institution | 35,900 | Added More | 27,500 | 327.38 % | $441,570 | $342,845 | $-98,725 | -22.35 % | $-75,625 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Ascend Capital Llc | Institution | 116,305 | New Holding | 116,305 | 100 % | $1,430,552 | $1,110,713 | $-319,839 | -22.35 % | $-319,839 | | | | | | News Article | History of Ascend Capital Llc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Axa | Institution | 45,577 | Sold Some | -76,323 | -62.61 % | $560,597 | $435,260 | $-125,337 | -22.35 % | $209,888 | | | | | | News Article | History of Axa Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Barclays Plc | Institution | 1,971 | Added More | 309 | 18.59 % | $24,243 | $18,823 | $-5,420 | -22.35 % | $-850 | | | | | | News Article | History of Barclays Plc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Batterymarch Financial Management Inc | Institution | 19,960 | New Holding | 19,960 | 100 % | $245,508 | $190,618 | $-54,890 | -22.35 % | $-54,890 | | | | | | News Article | History of Batterymarch Financial Management Inc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Credit Agricole S A | Institution | 1,750 | Sold Some | -21,953 | -92.61 % | $21,525 | $16,713 | $-4,813 | -22.35 % | $60,371 | | | | | | News Article | History of Credit Agricole S A Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Gartmore Mutual Fund Capital Trust | Institution | 125 | New Holding | 125 | 100 % | $1,538 | $1,194 | $-344 | -22.35 % | $-344 | | | | | | News Article | History of Gartmore Mutual Fund Capital Trust Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Geode Capital Management Llc | Institution | 97,746 | Added More | 46,787 | 91.81 % | $1,202,276 | $933,474 | $-268,802 | -22.35 % | $-128,664 | | | | | | News Article | History of Geode Capital Management Llc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Goldman Sachs Group Inc | Institution | 36,998 | Added More | 23,402 | 172.12 % | $455,075 | $353,331 | $-101,745 | -22.35 % | $-64,356 | | | | | | News Article | History of Goldman Sachs Group Inc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Henderson Group Plc | Institution | 5,500 | New Holding | 5,500 | 100 % | $67,650 | $52,525 | $-15,125 | -22.35 % | $-15,125 | | | | | | News Article | History of Henderson Group Plc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Jefferies Group Inc | Institution | 20,300 | New Holding | 20,300 | 100 % | $249,690 | $193,865 | $-55,825 | -22.35 % | $-55,825 | | | | | | News Article | History of Jefferies Group Inc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Knight Capital Group Inc | Institution | | Sold All | -27,157 | -100 % | | | | -22.35 % | $74,682 | | | | | | News Article | History of Knight Capital Group Inc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | New York State Common Retirement Fund | Institution | 1,400 | New Holding | 1,400 | 100 % | $17,220 | $13,370 | $-3,850 | -22.35 % | $-3,850 | | | | | | News Article | History of New York State Common Retirement Fund Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Paradigm Asset Management Co Llc | Institution | 37,800 | New Holding | 37,800 | 100 % | $464,940 | $360,990 | $-103,950 | -22.35 % | $-103,950 | | | | | | News Article | History of Paradigm Asset Management Co Llc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Price T Rowe Associates Inc | Institution | 449,500 | Sold Some | -220,900 | -32.95 % | $5,528,850 | $4,292,725 | $-1,236,125 | -22.35 % | $607,475 | | | | | | News Article | History of Price T Rowe Associates Inc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Dain Rauscher Inc | Institution | 3,431 | New Holding | 3,431 | 100 % | $42,201 | $32,766 | $-9,435 | -22.35 % | $-9,435 | | | | | | News Article | History of Rbc Dain Rauscher Inc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Renaissance Technologies Corp | Institution | | Sold All | -56,800 | -100 % | | | | -22.35 % | $156,200 | | | | | | News Article | History of Renaissance Technologies Corp Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Spark Lp | Institution | | Sold All | -23,300 | -100 % | | | | -22.35 % | $64,075 | | | | | | News Article | History of Spark Lp Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Suttonbrook Capital Management Lp | Institution | | Sold All | -593,344 | -100 % | | | | -22.35 % | $1,631,696 | | | | | | News Article | History of Suttonbrook Capital Management Lp Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Toronto Dominion Bank | Institution | 30,200 | New Holding | 30,200 | 100 % | $371,460 | $288,410 | $-83,050 | -22.35 % | $-83,050 | | | | | | News Article | History of Toronto Dominion Bank Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Tudor Investment Corp Et Al | Institution | 29,725 | New Holding | 29,725 | 100 % | $365,618 | $283,874 | $-81,744 | -22.35 % | $-81,744 | | | | | | News Article | History of Tudor Investment Corp Et Al Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Vanguard Group Inc | Institution | 773,721 | Added More | 172,138 | 28.61 % | $9,516,768 | $7,389,036 | $-2,127,733 | -22.35 % | $-473,380 | | | | | | News Article | History of Vanguard Group Inc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-12 | 2009-10-30 | 13F-HR | Td Asset Management Inc | Institution | 24,400 | Sold Some | -11,100 | -31.26 % | $294,996 | $233,020 | $-61,976 | -21.00 % | $28,194 | | | | | | News Article | History of Td Asset Management Inc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Bank Of America Corp | Institution | 84,345 | Added More | 120 | 0.14 % | $1,019,731 | $805,495 | $-214,236 | -21.00 % | $-305 | | | | | | News Article | History of Bank Of America Corp Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Barclays Global Investors Uk Holdings Ltd | Institution | 1,553,908 | Added More | 103,304 | 7.12 % | $18,786,748 | $14,839,821 | $-3,946,926 | -21.00 % | $-262,392 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Chicago Equity Partners Llc | Institution | 14,200 | New Holding | 14,200 | 100 % | $171,678 | $135,610 | $-36,068 | -21.00 % | $-36,068 | | | | | | News Article | History of Chicago Equity Partners Llc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Credit Suisse | Institution | 77,107 | New Holding | 77,107 | 100 % | $932,224 | $736,372 | $-195,852 | -21.00 % | $-195,852 | | | | | | News Article | History of Credit Suisse Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR/A | Ing Investment Management Co | Institution | 10,490 | Added More | 1,390 | 15.27 % | $126,824 | $100,180 | $-26,645 | -21.00 % | $-3,531 | | | | | | News Article | History of Ing Investment Management Co Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Merrill Lynch And Co Inc | Institution | 78,518 | Added More | 74,918 | 2081.05 % | $949,283 | $749,847 | $-199,436 | -21.00 % | $-190,292 | | | | | | News Article | History of Merrill Lynch And Co Inc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Mfc Global Investment Management Usa Ltd | Institution | 20,784 | Added More | 1,043 | 5.28 % | $251,279 | $198,487 | $-52,791 | -21.00 % | $-2,649 | | | | | | News Article | History of Mfc Global Investment Management Usa Ltd Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Oshaughnessy Asset Management Llc | Institution | | Sold All | -249 | -100 % | | | | -21.00 % | $632 | | | | | | News Article | History of Oshaughnessy Asset Management Llc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Ii Inc | Institution | 28,128 | Added More | 27,418 | 3861.69 % | $340,068 | $268,622 | $-71,445 | -21.00 % | $-69,642 | | | | | | News Article | History of Padco Advisors Ii Inc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Inc | Institution | 192,680 | Added More | 192,110 | 33703.50 % | $2,329,501 | $1,840,094 | $-489,407 | -21.00 % | $-487,959 | | | | | | News Article | History of Padco Advisors Inc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Susquehanna International Group Llp | Institution | 32,739 | Sold Some | -109,813 | -77.03 % | $395,815 | $312,657 | $-83,157 | -21.00 % | $278,925 | | | | | | News Article | History of Susquehanna International Group Llp Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Technical Financial Services Llc | Institution | 27,300 | New Holding | 27,300 | 100 % | $330,057 | $260,715 | $-69,342 | -21.00 % | $-69,342 | | | | | | News Article | History of Technical Financial Services Llc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Virginia Retirement Systems Et Al | Institution | 51,200 | Added More | 38,900 | 316.26 % | $619,008 | $488,960 | $-130,048 | -21.00 % | $-98,806 | | | | | | News Article | History of Virginia Retirement Systems Et Al Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Baker Bros Advisors Llc | Institution | 5,563,615 | No Change | 0 | 0 % | $65,595,021 | $53,132,523 | $-12,462,498 | -18.99 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Citigroup Inc | Institution | 23,665 | Added More | 4,716 | 24.88 % | $279,010 | $226,001 | $-53,010 | -18.99 % | $-10,564 | | | | | | News Article | History of Citigroup Inc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Comerica Bank | Institution | 32,518 | Added More | 2,518 | 8.39 % | $383,387 | $310,547 | $-72,840 | -18.99 % | $-5,640 | | | | | | News Article | History of Comerica Bank Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Royce And Associates Llc | Institution | | Sold All | -90,000 | -100 % | | | | -18.99 % | $201,600 | | | | | | News Article | History of Royce And Associates Llc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Tesseract Capital Llc | No Data | 11,400 | Added More | 9,493 | 497.79 % | $134,406 | $108,870 | $-25,536 | -18.99 % | $-21,264 | | | | | | News Article | History of Tesseract Capital Llc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Ubs Ag | Institution | 261,397 | Sold Some | -141,876 | -35.18 % | $3,081,871 | $2,496,341 | $-585,529 | -18.99 % | $317,802 | | | | | | News Article | History of Ubs Ag Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Federated Investors Inc | Institution | 12,273 | New Holding | 12,273 | 100 % | $134,880 | $117,207 | $-17,673 | -13.10 % | $-17,673 | | | | | | News Article | History of Federated Investors Inc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Icc Capital Management Inc | Institution | | Sold All | -200 | -100 % | | | | -13.10 % | $288 | | | | | | News Article | History of Icc Capital Management Inc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Klingenstein Fields And Co Llc | Institution | | Sold All | -88,900 | -100 % | | | | -13.10 % | $128,016 | | | | | | News Article | History of Klingenstein Fields And Co Llc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Deere And Co | Institution | 17,858 | New Holding | 17,858 | 100 % | $201,438 | $170,544 | $-30,894 | -15.33 % | $-30,894 | | | | | | News Article | History of Deere And Co Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Pnc Financial Services Group Inc | Institution | 1,348 | New Holding | 1,348 | 100 % | $15,205 | $12,873 | $-2,332 | -15.33 % | $-2,332 | | | | | | News Article | History of Pnc Financial Services Group Inc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Schwab Charles Investment Management Inc | Institution | 1,400 | No Change | 0 | 0 % | $15,792 | $13,370 | $-2,422 | -15.33 % | $0 | | | | | | News Article | History of Schwab Charles Investment Management Inc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Teachers Advisors Inc | Institution | 19,535 | Sold Some | -58,082 | -74.83 % | $220,355 | $186,559 | $-33,796 | -15.33 % | $100,482 | | | | | | News Article | History of Teachers Advisors Inc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Tiaa Cref Investment Management Llc | Institution | 128,311 | Sold Some | -8,491 | -6.20 % | $1,447,348 | $1,225,370 | $-221,978 | -15.33 % | $14,689 | | | | | | News Article | History of Tiaa Cref Investment Management Llc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Tradeworx Inc | Institution | 61,061 | New Holding | 61,061 | 100 % | $616,716 | $583,133 | $-33,584 | -5.44 % | $-33,584 | | | | | | News Article | History of Tradeworx Inc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-04 | 2009-08-31 | N-CSR | Ssga Funds - Ssga Enhanced Small Cap Fund | Small-Cap Core | 1,580 | New Holding | 1,580 | 100 % | $15,958 | $15,089 | $-869 | -5.44 % | $-869 | | | | | | News Article | History of Ssga Funds - Ssga Enhanced Small Cap Fund Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-04 | 2009-08-31 | N-CSR | Ssga Funds - Ssga Small Cap Fund | Small-Cap Core | 4,120 | New Holding | 4,120 | 100 % | $41,612 | $39,346 | $-2,266 | -5.44 % | $-2,266 | | | | | | News Article | History of Ssga Funds - Ssga Small Cap Fund Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Robeco Investment Management Inc | Institution | 19,115 | New Holding | 19,115 | 100 % | $170,697 | $182,548 | $11,851 | 6.94 % | $11,851 | | | | | | News Article | History of Robeco Investment Management Inc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Dimensional Fund Advisors Inc | Institution | 785,401 | Added More | 40,500 | 5.43 % | $7,162,857 | $7,500,580 | $337,722 | 4.71 % | $17,415 | | | | | | News Article | History of Dimensional Fund Advisors Inc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I - Health Sciences Fund | Health/Biotech | 30,600 | New Holding | 30,600 | 100 % | $279,072 | $292,230 | $13,158 | 4.71 % | $13,158 | | | | | | News Article | History of Valic Co I - Health Sciences Fund Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I - Small Cap Index Fund | Small-Cap Core | 17,349 | New Holding | 17,349 | 100 % | $158,223 | $165,683 | $7,460 | 4.71 % | $7,460 | | | | | | News Article | History of Valic Co I - Small Cap Index Fund Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-10-28 | 2009-09-30 | 13F-HR | Tradelink Llc | Institution | 14,000 | Sold Some | -2,600 | -15.66 % | $128,520 | $133,700 | $5,180 | 4.03 % | $-962 | | | | | | News Article | History of Tradelink Llc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-10-26 | 2009-06-30 | 13F-HR/A | Ameriprise Financial Inc | Institution | 8,400 | New Holding | 8,400 | 100 % | $91,896 | $80,220 | $-11,676 | -12.70 % | $-11,676 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-10-23 | 2009-09-30 | 13F-HR | Rbc Bank Usa Trust Department | No Data | | Sold All | -2,000 | -100 % | | | | -1.13 % | $220 | | | | | | News Article | History of Rbc Bank Usa Trust Department Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Inc | No Data | | Sold All | -19,160 | -100 % | | | | -3.04 % | $5,748 | | | | | | News Article | History of Blackrock Inc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Investment Management Llc | Institution | 92,986 | Added More | 12,858 | 16.04 % | $915,912 | $888,016 | $-27,896 | -3.04 % | $-3,857 | | | | | | News Article | History of Blackrock Investment Management Llc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Regions Financial Corp | Institution | 51,050 | Sold Some | -15,363 | -23.13 % | $502,843 | $487,528 | $-15,315 | -3.04 % | $4,609 | | | | | | News Article | History of Regions Financial Corp Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Bank Of New York Mellon Corp | Institution | 125,639 | Added More | 31,610 | 33.61 % | $1,199,852 | $1,199,852 | $0 | 0.00 % | $0 | | | | | | News Article | History of Bank Of New York Mellon Corp Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | State Board Of Administration Of Florida Retirement System | Institution | 38,472 | Added More | 15,372 | 66.54 % | $367,408 | $367,408 | $0 | 0.00 % | $0 | | | | | | News Article | History of State Board Of Administration Of Florida Retirement System Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-10-20 | 2009-09-30 | 13F-HR | Public Employees Retirement Association Of Colorado | Institution | 82,800 | New Holding | 82,800 | 100 % | $761,760 | $790,740 | $28,980 | 3.80 % | $28,980 | | | | | | News Article | History of Public Employees Retirement Association Of Colorado Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-10-19 | 2009-09-30 | 13F-HR | Hanseatic Management Services Inc | Institution | 7,400 | New Holding | 7,400 | 100 % | $72,298 | $70,670 | $-1,628 | -2.25 % | $-1,628 | | | | | | News Article | History of Hanseatic Management Services Inc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-10-19 | 2009-09-30 | 13F-HR | Strs Ohio | Institution | 33,300 | Sold Some | -19,171 | -36.53 % | $325,341 | $318,015 | $-7,326 | -2.25 % | $4,218 | | | | | | News Article | History of Strs Ohio Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Harris Financial Corp | Institution | 15,350 | Added More | 3,450 | 28.99 % | $145,365 | $146,593 | $1,228 | 0.84 % | $276 | | | | | | News Article | History of Harris Financial Corp Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Public Employees Retirement System Of Ohio | Institution | 26,242 | Added More | 100 | 0.38 % | $248,512 | $250,611 | $2,099 | 0.84 % | $8 | | | | | | News Article | History of Public Employees Retirement System Of Ohio Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-10-14 | 2009-09-30 | 13F-HR | Dorsey Wright Associates | Institution | 127 | New Holding | 127 | 100 % | $1,163 | $1,213 | $50 | 4.25 % | $50 | | | | | | News Article | History of Dorsey Wright Associates Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-10-08 | 2009-09-30 | 13F-HR | Rhumbline Advisers | Institution | 26,800 | Sold Some | -200 | -0.74 % | $216,008 | $255,940 | $39,932 | 18.48 % | $-298 | | | | | | News Article | History of Rhumbline Advisers Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-10-06 | 2009-09-30 | 13F-HR | Franklin Street Advisors Inc | Institution | 198,000 | Sold Some | -47,000 | -19.18 % | $1,633,500 | $1,890,900 | $257,400 | 15.75 % | $-61,100 | | | | | | News Article | History of Franklin Street Advisors Inc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Core Equity Portfolio | International Small-Mid-Cap Value | 49,757 | New Holding | 49,757 | 100 % | $407,012 | $475,179 | $68,167 | 16.74 % | $68,167 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Core Equity Portfolio Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Vector Equity Portfolio | No Data | 22,476 | New Holding | 22,476 | 100 % | $183,854 | $214,646 | $30,792 | 16.74 % | $30,792 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Vector Equity Portfolio Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio | No Data | 600 | New Holding | 600 | 100 % | $4,908 | $5,730 | $822 | 16.74 % | $822 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Fidelity Charles Street Trust - Fidelity Global Balanced Fund | Global Flex Port | 16,000 | New Holding | 16,000 | 100 % | $130,880 | $152,800 | $21,920 | 16.74 % | $21,920 | | | | | | News Article | History of Fidelity Charles Street Trust - Fidelity Global Balanced Fund Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Seligman Global Fund Series Inc - Global Smaller Companies Fund | Global Small/Mid-Cap Core | | Sold All | -37,400 | -100 % | | | | 16.74 % | $-51,238 | | | | | | News Article | History of Seligman Global Fund Series Inc - Global Smaller Companies Fund Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Old Westbury Funds Inc - International Fund | International Multi-Cap Core | 7,614 | No Change | 0 | 0 % | $63,348 | $72,714 | $9,365 | 14.78 % | $0 | | | | | | News Article | History of Old Westbury Funds Inc - International Fund Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-09-24 | 2009-06-30 | 13F-HR/A | Credit Agricole S A | Institution | 23,703 | New Holding | 23,703 | 100 % | $198,157 | $226,364 | $28,207 | 14.23 % | $28,207 | | | | | | News Article | History of Credit Agricole S A Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-09-17 | 2009-07-31 | N-Q | Rydex Etf Trust - Rydex Inverse Russell 2000 Etf | Specialty & Misc | 460 | New Holding | 460 | 100 % | $4,522 | $4,393 | $-129 | -2.84 % | $-129 | | | | | | News Article | History of Rydex Etf Trust - Rydex Inverse Russell 2000 Etf Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-09-11 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 1,450,604 | Added More | 465,753 | 47.29 % | $15,477,945 | $13,853,268 | $-1,624,676 | -10.49 % | $-521,643 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Series Funds - Banking Fund | Financial Services | 570 | New Holding | 570 | 100 % | $5,957 | $5,444 | $-513 | -8.61 % | $-513 | | | | | | News Article | History of Rydex Series Funds - Banking Fund Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Variable Trust - Biotechnology Fund | Health/Biotech | 280 | New Holding | 280 | 100 % | $2,926 | $2,674 | $-252 | -8.61 % | $-252 | | | | | | News Article | History of Rydex Variable Trust - Biotechnology Fund Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqalliancebernstein Small Cap Growth Portfolio | Small-Cap Growth | 37,500 | New Holding | 37,500 | 100 % | $427,500 | $358,125 | $-69,375 | -16.22 % | $-69,375 | | | | | | News Article | History of Eq Advisors Trust - Eqalliancebernstein Small Cap Growth Portfolio Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqalliancebernstein Value Portfolio | Multi-Cap Value | 4,400 | New Holding | 4,400 | 100 % | $50,160 | $42,020 | $-8,140 | -16.22 % | $-8,140 | | | | | | News Article | History of Eq Advisors Trust - Eqalliancebernstein Value Portfolio Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqbond Index Portfolio | Specialty & Misc | 84,300 | New Holding | 84,300 | 100 % | $961,020 | $805,065 | $-155,955 | -16.22 % | $-155,955 | | | | | | News Article | History of Eq Advisors Trust - Eqbond Index Portfolio Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Vanguard Variable Insurance Funds - Small Company Growth Portfolio | Small-Cap Growth | 6,000 | New Holding | 6,000 | 100 % | $68,400 | $57,300 | $-11,100 | -16.22 % | $-11,100 | | | | | | News Article | History of Vanguard Variable Insurance Funds - Small Company Growth Portfolio Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund - Pd Small-Cap Growth Index Portfolio | No Data | 328 | No Compare | | | $3,713 | $3,132 | $-581 | -15.63 % | | | | | | | News Article | History of Pacific Select Fund - Pd Small-Cap Growth Index Portfolio Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund - Small-Cap Index Portfolio | No Data | 11,300 | New Holding | 11,300 | 100 % | $127,916 | $107,915 | $-20,001 | -15.63 % | $-20,001 | | | | | | News Article | History of Pacific Select Fund - Small-Cap Index Portfolio Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Amvescap Plc | Institution | 15,796 | Sold Some | -15,796 | -50.00 % | $182,286 | $150,852 | $-31,434 | -17.24 % | $31,434 | | | | | | News Article | History of Amvescap Plc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Fidelity International Ltd | Institution | 747,842 | New Holding | 747,842 | 100 % | $8,630,097 | $7,141,891 | $-1,488,206 | -17.24 % | $-1,488,206 | | | | | | News Article | History of Fidelity International Ltd Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Tiaa Cref Life Fund - Stock Index Fund | Specialty & Misc | 254 | New Holding | 254 | 100 % | $3,167 | $2,426 | $-742 | -23.41 % | $-742 | | | | | | News Article | History of Tiaa Cref Life Fund - Stock Index Fund Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Nasdaq Biotechnology Index Fund | Health/Biotech | 334,145 | Sold Some | -16,128 | -4.60 % | $4,203,544 | $3,191,085 | $-1,012,459 | -24.08 % | $48,868 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 2000 Growth Index Fund | Multi-Cap Growth | 153,761 | New Holding | 153,761 | 100 % | $1,934,313 | $1,468,418 | $-465,896 | -24.08 % | $-465,896 | | | | | | News Article | History of Ishares Trust - Ishares Russell 2000 Growth Index Fund Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 2000 Index Fund | Specialty & Misc | 257,041 | New Holding | 257,041 | 100 % | $3,233,576 | $2,454,742 | $-778,834 | -24.08 % | $-778,834 | | | | | | News Article | History of Ishares Trust - Ishares Russell 2000 Index Fund Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Growth Index Fund | Multi-Cap Growth | 1,291 | New Holding | 1,291 | 100 % | $16,241 | $12,329 | $-3,912 | -24.08 % | $-3,912 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Growth Index Fund Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Index Fund | Specialty & Misc | 6,338 | New Holding | 6,338 | 100 % | $79,732 | $60,528 | $-19,204 | -24.08 % | $-19,204 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Index Fund Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell Microcap Index Fund | Specialty & Misc | 31,235 | Added More | 6,566 | 26.61 % | $392,936 | $298,294 | $-94,642 | -24.08 % | $-19,895 | | | | | | News Article | History of Ishares Trust - Ishares Russell Microcap Index Fund Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | 13F-HR/A | Wells Fargo And Co | Institution | 19,600 | Added More | 1,700 | 9.49 % | $246,568 | $187,180 | $-59,388 | -24.08 % | $-5,151 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Equity Index Fund | Specialty & Misc | 14,522 | New Holding | 14,522 | 100 % | $174,700 | $138,685 | $-36,015 | -20.61 % | $-36,015 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Equity Index Fund Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Extended Market Index Fund | Mid-Cap Core | 229,794 | New Holding | 229,794 | 100 % | $2,764,422 | $2,194,533 | $-569,889 | -20.61 % | $-569,889 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Extended Market Index Fund Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Total Stock Market Index Fund | Multi-Cap Core | 233,393 | New Holding | 233,393 | 100 % | $2,807,718 | $2,228,903 | $-578,815 | -20.61 % | $-578,815 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Total Stock Market Index Fund Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 6,000 | No Change | 0 | 0 % | $72,180 | $57,300 | $-14,880 | -20.61 % | $0 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of Biocryst Pharmaceuticals Inc |
RSS feed for BCRX